Leverage your data to drive clinical outcomes
Accelerate innovation with real world data
Log in to the OMNY Health Platform
Learn more about OMNY Health
Join our rapidly growing team
Meet our team at upcoming events
Keep up with the latest news
Keep the conversation going
OMNY Health’s GI partnerships are a pivotal step in its mission to deliver data and insights to accelerate life-changing innovation. With a focus on catalyzing research and improving outcomes, OMNY aims to make a tangible difference for the millions of individuals in...
In late 2022, the technology world was turned upside down as OpenAI released ChatGPT, its new artificial intelligence (AI) model. Unlike most previous natural language processing (NLP) models, this model contained billions of parameters, was trained on a corpus of...
On November 6 - November 9, 2022, this poster was on display at ISPOR Europe 2022 What is the Objective of this Poster? The objective of this study was to characterize real-world treatment patterns among wet AMD patients in diverse healthcare delivery settings in the...
On August 23 – August 25, 2021, this poster was on display at ICPE 2021 What is the Objective of this Poster? To characterize differences in AVSI patients who received TAVR and SAVR To compare post-procedural occurence of death, atrial fibrillation (AF), and adverse...
On August 23-August 25, 2021, this presentation was on display at ICPE 2021 What is the Objective of this Presentation? To characterize treatment patterns in children with COVID-19 in the real-world hospital setting Focus will be on therapy classes in...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? ADEs and ADRs represent significant burden to the healthcare system Can account for 1-5% of hospital admissions overall, and up to 10% for elderly Can occur...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Clinical outcomes were similar between SR and MR cohorts, including:– Mortality (% [95% confidence interval]) (1.1% [0.6%- 2.0%] vs 0.3% [0.0% - 2.0%]),–...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world treatment patterns for AD within large dermatology specialty networks in the United States. As new treatments are...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world treatment patters for AA within a diverse set of US healthcare settings. ILCS and TCS were by far the most common...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insight into characteristics and treatments of pediatric HS within a diverse set of US healthcare setting. Acne presented as the most common...
By continuing to use the site, you agree to the use of cookies. More information.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below, then you are consenting to this.